By Jim
Geraghty
Wednesday,
December 14, 2022
The Morning
Jolt, back on December 28, 2021: “When Will the Rest of the World Call Out China’s Insanely Implausible
Covid-19 Statistics?”
Apparently,
it took about a year. This
morning’s New York Times:
Despite those assurances, China faces much uncertainty over how the
coming months will play out. Information is opaque and unreliable, which will
make it difficult to gauge Beijing’s handling of the coming wave of Covid infections.
The government’s desire to save face after an embarrassing retreat from its
hallmark pandemic policy will only muddy the picture. . . .
Some of China’s data stretches the boundaries of reason for a country
with a population of 1.4 billion people. China said there had not been a single
Covid-related death since it lifted pandemic restrictions six days ago. By
comparison, the United States reported 469 Covid-related deaths on Tuesday
alone.
Since the early months of the pandemic, virologists have raised
questions about China’s official mortality figures, challenging the way that
the country’s hospitals classify Covid deaths. Instead of including people who
died after contracting Covid-19 in official data, as is the norm in other
countries, Chinese hospitals typically attribute deaths to pre-existing or
chronic illnesses, such as cancer or a heart condition, they said.
Underreporting Covid cases is not unique to China, but the country is
especially opaque.
To hear
the Chinese government tell it, its country ranks 98th in the world
in total cases of Covid-19 recorded, with fewer cases than Oman, Armenia,
Honduras, Qatar, Estonia, Cyprus, and Kuwait. Never mind that the Chinese
population of 1.4 billion is the largest in the world, the virus originated in
China, and many Chinese live in close quarters in big cities where social
distancing is impossible. The government’s official figure of 369,000 or so
total cases is about half that of Paraguay, one-third that of Cuba, one-quarter
that of Norway, one-fifth that of Slovakia, and roughly one-tenth that of
Romania.
Back
when the U.S. was reporting more than 200,000 cases of Covid-19 per day —
approaching the peak of the Omicron wave — China insisted that across the whole
country, there were nine cases. As I wrote back then, “Even if
we want to give Chinese policies of city-wide lockdowns and quarantining people by welding
apartment doors shut the
broadest possible benefit of the doubt, it’s simply not plausible that a virus
that has proven wildly contagious in every other country suddenly became shy
and socially-awkward once it entered the jurisdiction of the Chinese Communist
Party.”
Skepticism
of China’s numbers and narrative isn’t just rising now, and it isn’t just
confined to the New York Times. But it does feel like it took a
long while for that well-justified skepticism to kick in and reshape the narratives
around China here in the West. As early as
February 2020,
experts looked at the country’s outbreak numbers and concluded that they didn’t
add up. You may recall in April 2020 when the country’s total number of cases
reported increased by precisely 50 percent — and then remained flat for roughly
two years.
This
past April, the Washington Post editorial
board concluded that,
“The death toll reported by China in the early part of the pandemic was most
likely a very small
fraction of
those who actually perished. . . . Biologically, the virus in China — the
omicron BA.2 subvariant — isn’t that different from elsewhere. What does make
China stand apart is a government that is intent on propagating a narrative
that it is doing an exceptional job in managing the pandemic.”
The
Economist runs an
ongoing project looking
at countries’ reported death figures, comparing them to the average death rate
before the pandemic, and attempting to extrapolate the excess deaths compared
to “normal.” Officially China has seen just 5,235 deaths from Covid-19 since
the start of the pandemic. The Economist calculates that since
the pandemic began, China has seen anywhere from 8,900 to 2.6 million more
deaths than it normally would have.
One
other aspect of the Chinese government’s denial is an overestimation
of the effectiveness of its homegrown vaccines. Those vaccines just don’t work as well as the
ones developed in the U.S., Europe, and hey, go
figure, even Russia.
China says that 90 percent of its population is vaccinated, but somehow, when
trying to mitigate a virus that is most deadly to the elderly, the Chinese
government has failed to vaccinate the
elderly: “The
government announced a little over a week ago that
around 30 percent of people aged 60 and up — or roughly 80 million people —
were not vaccinated and boosted as of Nov. 11. Among those 80 or older, the
ratio was closer to 60 percent.” (Considering the far-reaching power of the
Chinese government to compel its citizens to obey orders, you can be forgiven
for wondering if the failure to vaccinate the most elderly is entirely
accidental.)
In
fact, the Chinese
government vaccinated citizens ages 18 to 59 before it vaccinated those 60 and older. This
fueled the perception among some Chinese that the vaccine wasn’t safe for the
elderly.
NPR lays out how some Chinese are hesitant
to get shots of homegrown vaccines because of “product quality issues that have
for years plagued manufacturing in China — including its production of
pharmaceuticals. . . . Lax oversight and corruption during recent decades of
breakneck economic growth has led to a string of product quality scandals in
China — from baby formula cut with industrial chemicals to contaminated blood thinner and tainted vaccines.” Sometimes, you open
a package of something made in China, like a new iPhone, and it works, right
out of the box. Sometimes, you order a toy or kid’s bicycle and there are parts
missing, extra parts, or the instructions are poorly written, and you can tell
no one’s paying close attention to the products going out the door. Who wants
to apply that hit-and-miss professionalism to something that’s put into your
bloodstream?
This is
the kind of uncomfortable subject some may prefer to avoid, lest they be
accused of some sort of xenophobia. But the quality-control problems that
plague Chinese manufacturers won’t go away if you pretend they don’t
exist. Chinese
citizens know which vaccines they trust:
Chinese mainland residents are rushing to Macao to get BioNTech’s
messenger RNA-based COVID-19 vaccines as infections surge amid the government’s
easing of pandemic controls.
Mainland tourist Ni Lin (an alias) went to the hospital of Macao University
of Science and Technology Saturday, the last day of his visit to Macao, to
receive the mRNA vaccine, also known as Comirnaty. He said more than 100
mainland tourists got the shot the same day, and many of them flew to Macao for
that purpose alone.
mRNA vaccines, led by products developed by Pfizer-BioNTech and Moderna,
are not approved in the Chinese mainland, even though they are widely used
around the world.
Now,
China has finally — finally — recognized that an endless series of intermittent
lockdowns in the name of “Covid Zero” is unsustainable. But this means allowing
the Chinese people to live their lives, not well vaccinated, with an extremely
contagious virus floating around, with a whole bunch of unvaccinated
elderly. Nobody knows
exactly how this will shake out, but it won’t be good:
A study based on vaccination rates in March, published in Nature
Medicine in May, found that lifting zero-COVID
restrictions at that point could “generate a tsunami of COVID-19 cases” over a 6-month
period, with 112 million symptomatic cases, 2.7 million intensive care unit
(ICU) admissions, and 1.6 million deaths. Peak demand for ICU beds would hit 1
million, more than 15 times the current capacity.
There’s
an interesting parallel between China’s unreliable health data and the
country’s unreliable economic data. Year by year, China has released less and
less economic data — by 2016, more than half of all
indicators published by the national and municipal statistics bureaus in 2012
had been quietly discontinued, according to the Financial Times’ John Burn Murdoch. It’s
a safe assumption that if the figures showed good news, the Chinese government
would be bragging about them.
Earlier this
year, Luis
Martinez, an assistant professor at the University of Chicago, examined the
light from countries from satellite photos, year by year, and used that as a
measuring stick of economic development. (More economic growth means more
buildings, and more buildings means more light at night.) His research
indicated that, “Autocracies overstate their yearly GDP growth by approximately
35 percent.” Maybe China’s exaggerations are a little less, maybe they’re a
little more. But the implications of this longstanding embellishment of economic
power are extremely consequential for geopolitical perceptions. Maybe China
isn’t the rising superpower — about to overtake the U.S. — that so many inside
and outside of China have claimed for years. Maybe it’s a lot of smoke and
mirrors, hiding a system that is a lot more inflexible, rickety, and slipshod
than any Chinese leader was ever willing to admit. (If the Chinese economy is a
lot weaker than it looks, held aloft by hype . . . well, that’s just one more
example of the Fortune magazine cover jinx.)
Surely
we all remember the old 1980s anti-drug public-service
announcement, “This
is your drugs . . . this is your brain on drugs . . . any questions?” Well,
autocracies fry your brain, too. They make the entire country turn itself
inside out to cater to the arbitrary whims of one man — whether that man is Xi
Jinping, Vladimir Putin, or Kim Jong-un. Once the leader makes a decision,
everyone has to pretend it was the right decision, no matter how much the
evidence piles up that it was a terrible mistake. China can’t admit that other
countries’ vaccines work more effectively, and it certainly can’t be seen
asking for help. Better that millions of people die than Xi
Jinping admit that the West has a better solution to anything, much less a
problem as serious as Covid-19. This is the same mentality that had the
Chinese government insisting that Covid-19 was not contagious for the first
month or so of
the outbreak.
It would
be easier to ignore the problems of autocracies if their problems stayed within
their own borders. But as we saw with Covid, they don’t. And in the case of
Russia, autocrats periodically want to redraw their borders through military
force.
No comments:
Post a Comment